Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 2 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on July 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Review of Infant Formula Nutrient Requirements

Closed
75F40126R00060Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 311514
DIBBS
UHT Milk Supply – Low Fat Banana FlavorThe contract entails the supply of shelf-stable, low-fat banana-flavored ultra-high temperature processed milk in one-gallon boxes to U.S. military installations through a subcontract arrangement under the Defense Logistics Agency. The product must meet stringent military specifications for safety, longevity, and nutritional content, ensuring it remains viable without refrigeration across diverse operational environments. The NAICS code 311514 indicates the industry classification as milk processing, aligning with the production of fortified dairy beverages intended for long-term storage and distribution. Deliveries are expected to support food service operations across Department of Defense locations, with performance spanning unspecified military bases throughout the United States. The solicitation was posted on July 16, 2026, and the contract reference numbers indicate an active award under the DLA's logistics framework, with fulfillment coordinated through established subcontracting channels. The packaging format of one-gallon boxes is designed for bulk use in mess halls and field rations, emphasizing ease of transport, storage efficiency, and consumer acceptability among service members. While specific volume, delivery timelines, and quality control benchmarks are not detailed here, adherence to military standards for UHT dairy products is mandatory, including strict limits on fat content, flavor consistency, and microbiological safety to ensure troop nutrition and readiness.
Defense Logistics Agency

POSTED

about 1 month ago

DEADLINE

N/A

AI Contract Overview

Show more

The Office of Critical Foods within the FDA’s Human Foods Program is seeking a contractor to conduct a comprehensive scientific review of nutrient requirements for infant formula, as mandated by the Food and Drug Omnibus Reform Act of 2022. This effort is part of Operation Stork Speed, a multi-agency initiative to ensure a reliable, safe, and nutritious supply of infant formula for U.S. infants, who often rely on it as their sole source of nutrition. The review must cover fourteen specific nutrients—protein, fat, linoleic acid, carbohydrates, iron, copper, zinc, calcium, phosphorus, magnesium, vitamin K, DHA, ARA, alpha-linolenic acid, and L-carnitine—and produce detailed assessments for each, including dietary reference intakes from national and international bodies, human milk composition data, daily intake estimates, nutrient functions and metabolism, deficiency and toxicity profiles, and current scientific literature on health outcomes and safety. The contractor is also required to evaluate existing regulatory standards under 21 CFR 107.100(a) and propose evidence-based revisions in alignment with the latest research and global infant formula standards. This contractual requirement is critical to fulfilling FDORA’s mandate for a quadrennial review of infant formula nutrient standards, the first of which is scheduled to begin in 2026. The contractor must deliver individual, high-quality Microsoft Word files for each nutrient, incorporating not only scientific data but also contextual considerations such as nutrient contributions from water used to reconstitute powdered formula and other dietary sources. The ultimate goal is to inform FDA’s regulatory decisions and ensure that infant formulas marketed in the United States continue to meet the evolving nutritional needs of healthy, full-term infants based on the most up-to-date and globally relevant science. The solicitation, issued under number 75F40126R00060, has a response deadline of July 27, 2026, and is managed by the FDA’s Office of Acquisition and Grant Services with primary point of contact Amanda Edger. The work will be conducted in support of the agency’s broader mission to safeguard infant health through science-based nutritional standards.

General Info

Contractor to review 14 infant formula nutrients per FDORA 2022, propose evidence-based regulatory revisions.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

311514 - Dry, Condensed, and Evaporated Dairy Product ManufacturingView NAICS

Place of Performance

College Park, MD, USA

Set-Aside

NONE

Documents

(2)

RFP 75F40126R00060 Review of Infant Formula Nutrient Requirements

PDFrfp

75F40126R00060 Pricing Worksheet

XLSXpricing-worksheet

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts

Full Description

Show more

The Office of Critical Foods (OCF) Infant Formula Premarket Review Staff (IFPRS) within the Food and Drug Administration’s (FDA) Human Foods Program (HFP) Nutrition Center of Excellence (NCE) is seeking information to assess the feasibility of fulfilling a highly specialized requirement related to the comprehensive review of infant formula nutrient requirements mandated by the Food and Drug Omnibus Reform Act (FDORA) and a component of Operation Stork Speed.


In March 2025, in coordination with the Department of Health and Human Services (HHS), FDA launched Operation Stork Speed (OSS)— a multi-pronged initiative to expand options for safe, reliable, and nutritious infant formula for American families. These enhanced commitments are focused on making sure a strong supply of infant formula—which is often the sole source of nutrition for infants—remains available for one of our nation’s most vulnerable populations. FDORA, enacted as part of the Consolidated Appropriations Act of 2023, mandates that FDA review infant formula nutrient requirements every four years, as appropriate, with the first review commencing in 2026. Although FDA regularly reviews individual nutrient requirements for infant formulas, the last comprehensive review was in 1998.


This comprehensive nutrient review for infant formulas intended for healthy, full-term infants will incorporate the latest scientific findings regarding human milk composition, infant nutritional needs, and developmental requirements to ensure infant formula products support healthy growth and development and help inform our regulatory decision-making. This process will ensure that infants benefit from the most up-to-date science and innovation as research continues to advance our understanding of infants’ dietary needs.


The Contractor shall obtain a comprehensive review of fourteen different nutrients for infant formula, including protein, fat, linoleic acid, carbohydrates, iron, copper, zinc, calcium, phosphorus, magnesium, vitamin K, DHA, ARA, alpha-linolenic acid, and L-carnitine.
• Obtain, for each nutrient, a unique Microsoft Word file including:
o National and International Expert Body Dietary Reference Intakes (DRIs) for healthy term infants.
o Global infant formula nutrient standards and recommendations (per 100 kcal).
o Nutrient content of human milk.
o Daily intake estimation, including comparison with DRIs and human milk exposure.
o A brief background on the nutrient, including function and metabolism, biomarkers, deficiency and toxicity, and nutrient interactions.
o Additional considerations. For example, other dietary sources of the nutrient, such as water used to reconstitute powdered infant formula.
o New or emerging scientific evidence regarding the nutrient, including clinical studies and health outcomes, safety data, and mechanistic studies.
• Proposed action and justification related to current requirements in 21 CFR 107.100(a).
• Fulfill the requirement of the Food and Drug Omnibus Reform Act of 2022 (FDORA), enacted as part of the Consolidated Appropriations Act of 2023, that FDA review infant formula nutrient requirements every four years, as appropriate, with the first review commencing in 2026. Per FDORA, such review must consider any new scientific data or information related to infant formula nutrients, including international infant formula standards.
• Use the information to initiate appropriate action to ensure that infant formulas marketed in the United States are nutritionally adequate to support healthy growth and development in infants.

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541715
New
Federal
Regulatory Science Tool for Transcranial Ultrasound Modeling
Solicitation # 75F40126Q00351
The FDA's Center for Devices and Radiological Health is soliciting a firm fixed price contract for the development of a Regulatory Science Tool for transcranial ultrasound modeling. The objective is to create a computational modeling package to simulate sonication protocols, standardize modeling techniques, and support regulatory review and patient safety. The scope of work includes performing validation and sensitivity analysis, developing baseline, best-case, and worst-case patient models, and establishing a standard reference tissue properties set. The contractor may utilize a single-technique or dual-technique approach, leveraging tools such as k-Wave or BabelViscoFDTD, to produce a software package compatible with Windows, Linux, and macOS. This unrestricted, simplified acquisition procurement is capped at 350,000 dollars with a performance period of 12 months from the date of award. To be eligible, the contractor's principal investigator must demonstrate significant expertise in TUS simulation through completed research projects or contributions to open-source tools. Award will be based on technical acceptability and a fair and reasonable price. The contractor must adhere to strict cybersecurity and privacy requirements, including the handling of Controlled Unclassified Information and the completion of mandatory HHS training. All deliverables will be inspected and accepted by the government at the destination.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

3 days ago

DEADLINE

in 3 days
View Details